Pasar al contenido principal

DESCIFRANDO EL PAPEL DE NUEVOS MEDIADORES INFLAMATORIOS DERIVADOS DE INTERFERON Y DE LA INEFICAZ RESOLUCION DE LA INFLAMACION EN EL DAÑO CARDIOVASCULAR ASOCIADO A HIPERTENSION

PID2020-116498RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction

  • Briones, Ana|||0000-0001-8218-5579
  • Hernanz, Raquel
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Val-Blasco, Almudena
  • Alonso, María Jesús|||0000-0003-4912-1121
  • Salaices Sanchez, Mercedes|||0000-0003-3323-1692
Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or interleukins increase oxidative stress and contractile prostanoids and the expression of adhesion molecules that reduce nitric oxide (NO) availability and bind leucocytes, thereby impairing endothelial function. Despite this evidence, anti-inflammatory therapies are not yet indicated for the treatment of most CVD. Resolution of inflammation is mediated by a family of specialized pro-resolving mediators (SPMs) that act on cognate G protein-coupled receptors to limit immune cell infiltration and initiate tissue repair. SPMs, generated from omega-3 and omega-6 polyunsaturated fatty acids, belong to four major families: lipoxins, resolvins, protectins and maresins. SPM receptors are expressed in immune and vascular cells where they regulate important processes such as phagocytosis and polarization, production of cytokines, NO and prostacyclin, and modulation of smooth muscle cell phenotype. Growing evidence in animal models demonstrates that activation of SPM receptors can protect vascular function and structure and provide beneficial effects in various CVD. We will review recent advances in the role of inflammation and SPMs in vascular (dys)function in hypertension, atherosclerosis, and aortic aneurysms.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Supplementation with the symbiotic formulation Prodefen® increases neuronal nitric oxide synthase and decreases oxidative stress in superior mesenteric artery from spontaneously hypertensive rats

  • Méndez-Albiñana, Pablo
  • Martínez-González, Miguel Ángel
  • Camacho-Rodríguez, Laura
  • Ferreira-Lazarte, Alvaro
  • Villamiel, Mar
  • Rodrigues-Díez, Raquel
  • Balfagón, Gloria
  • García-Redondo, Ana B.
  • Prieto-Nieto, Mª Isabel
  • Blanco-Rivero, Javier
This article belongs to the Special Issue Antioxidant Foods and Cardiometabolic Health., In recent years, gut dysbiosis has been related to some peripheral vascular alterations linked to hypertension. In this work, we explore whether gut dysbiosis is related to vascular innervation dysfunction and altered nitric oxide (NO) production in the superior mesenteric artery, one of the main vascular beds involved in peripheral vascular resistance. For this purpose, we used spontaneously hypertensive rats, either treated or not with the commercial synbiotic formulation Prodefen® (108 colony forming units/day, 4 weeks). Prodefen® diminished systolic blood pressure and serum endotoxin, as well as the vasoconstriction elicited by electrical field stimulation (EFS), and enhanced acetic and butyric acid in fecal samples, and the vasodilation induced by the exogenous NO donor DEA-NO. Unspecific nitric oxide synthase (NOS) inhibitor L-NAME increased EFS-induced vasoconstriction more markedly in rats supplemented with Prodefen®. Both neuronal NO release and neuronal NOS activity were enhanced by Prodefen®, through a hyperactivation of protein kinase (PK)A, PKC and phosphatidylinositol 3 kinase-AKT signaling pathways. The superoxide anion scavenger tempol increased both NO release and DEA-NO vasodilation only in control animals. Prodefen® caused an increase in both nuclear erythroid related factor 2 and superoxide dismutase activities, consequently reducing both superoxide anion and peroxynitrite releases. In summary, Prodefen® could be an interesting non-pharmacological approach to ameliorate hypertension., This research was funded by CiberCV (Grant number: CB16/11/00286), the Ministerio de Ciencia e Innovación (PID2020-116498RB-I00, and CDTI -Center for Industrial Technological Development-project PID 2020-FEDER Funds), and R+D projects for young researchers, Universidad Autónoma de Madrid-Comunidad de Madrid (SI1-PJI-2019-00321)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

  • Díaz del Campo, Lucía S.
  • García-Redondo, Ana B.
  • Rodríguez, Cristina
  • Zaragoza, Carlos
  • Duro-Sánchez, Santiago
  • Palmas, Francesco
  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Peraza, Diego A.
  • Rodrigues-Díez, Raquel
  • Valenzuela, Carmen
  • Dalli, Jesmond
  • Salaices, Mercedes
  • Briones, Ana M.
[Background]: Resolution of inflammation is orchestrated by specialized proresolving lipid mediators (SPMs), and this would be impaired in some cardiovascular diseases. Among SPMs, resolvins (Rv) have beneficial effects in cardiovascular pathologies, but little is known about their effect on cardiovascular damage in hypertension., [Methods:]: Aorta, small mesenteric arteries, heart, and peritoneal macrophages were taken from C57BL/6J mice, infused or not with angiotensin II (AngII; 1.44 mg/kg/day, 14 days) in presence or absence of resolvin D2 (RvD2) (100 ng/mice, every second day) starting 1 day before or 7 days after AngII infusion., [Results]: Enzymes and receptors involved in SPMs biosynthesis and signaling were increased in aorta or heart from AngII-infused mice. We also observed a differential regulation of SPMs in heart from these mice. Preventive treatment with RvD2 partially avoided AngII-induced hypertension and protected the heart and large and small vessels against functional and structural alterations induced by AngII. RvD2 increased the availability of vasoprotective factors, modified SPMs profile, decreased cardiovascular fibrosis, and increased the infiltration of pro-resolving macrophages. When administered in hypertensive animals with established cardiovascular damage, RvD2 partially improved cardiovascular function and structure, decreased fibrosis, reduced the infiltration of neutrophils, and shifted macrophage phenotype toward a pro-resolving phenotype., [Conclusions]: There is a disbalance between proinflammatory and resolution mediators in hypertension. RvD2 protects cardiovascular function and structure when administered before and after the development of hypertension by modulating vascular factors, fibrosis and inflammation. Activating resolution mechanisms by treatment with RvD2 may represent a novel therapeutic strategy for the treatment of hypertensive cardiovascular disease., This work is supported by SAF2016-80305P (to M. Salaices and A.M. Briones), SAF2016-75021-R (to C. Valenzuela) funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; PID2020-116498RB-I00 (to A.M. Briones), PID2019-104366RB-C21 (to C. Valenzuela) funded by MCIN/AEI/10.13039/501100011033, Grant from Comunidad de Madrid (CM) (B2017/BMD-3676 AORTASANA) FEDER— way to build Europe (to M. Salaices); Grant of the Instituto de Salud Carlos III PI21/01048 (to C. Rodríguez); Grant of Consejo Superior de Investigaciones Cientificas: 2019AEP148 (to C. Valenzuela). The study has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 954798 (to A.M. Briones). R. Rodrigues-Diez was supported by a Juan de la Cierva contract (IJCI-2017-31399). A. de Benito-Bueno is funded by the FPI (BES-2017-080184); P.G. Socuellamos is funded by the FPU (FPU17/02731). J. Dalli is supported by funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant no: 677542) and the Barts Charity (grant no: MGU0343)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors

  • Rodrigues-Diez, Raquel
  • Ballesteros-Martínez, Constanza
  • Moreno-Carriles, Rosa María
  • Nistal, Francisco
  • Díaz del Campo, Lucía S.
  • Cachofeiro, Victoria
  • Dalli, Jesmond
  • García-Redondo, Ana B.
  • Redondo, Juan M.
  • Salaices, Mercedes
  • Briones, Ana M.
During resolution of inflammation, specialized proresolving mediators (SPMs), including resolvins, are produced to restore tissue homeostasis. We hypothesized that there might be a dysregulation of SPMs pathways in pathological vascular remodeling and that resolvin D2 (RvD2) might prevent vascular remodeling and contractile and endothelial dysfunction in a model of obesity and hypertension. In aortic samples of patients with or without abdominal aortic aneurysms (AAA), we evaluated gene expression of enzymes involved in SPMs synthesis (ALOXs), SPMs receptors and pro-inflammatory genes. In an experimental model of aortic dilation induced by high fat diet (HFD, 60%, eighteen weeks) and angiotensin II (AngII) infusion (four weeks), we studied the effect of RvD2 administration in aorta and small mesenteric arteries structure and function and markers of inflammation. In human macrophages we evaluated the effects of AngII and RvD2 in macrophages function and SPMs profile. In patients, we found positive correlations between AAA and obesity, and between AAA and expression of ALOX15, RvD2 receptor GPR18, and pro-inflammatory genes. There was an inverse correlation between the expression of aortic ALOX15 and AAA growth rate. In the mice model, RvD2 partially prevented the HFD plus AngII-induced obesity and adipose tissue inflammation, hypertension, aortic and mesenteric arteries remodeling, hypercontratility and endothelial dysfunction, and the expression of vascular proinflammatory markers and cell apoptosis. In human macrophages, RvD2 prevented AngII-induced impaired efferocytosis and switched SPMs profile. RvD2 might represent a novel protective strategy in preventing vascular damage associated to hypertension and obesity likely through effects in vascular and immune cells., This work is supported by SAF2016-80305P, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, PID2020-116498RB-I00 to AMB and PID2021-122388OB-100 to JMR funded by MCIN/AEI/10.13039/501100011033, Comunidad de Madrid (CM) (B2017/BMD-3676 AORTASANA) FEDER-a way to build Europe, FIS PI21/00084 (Carlos III Health Institute) and INNVAL21/24 (IDIVAL) to FN, and the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 954798 to AMB and European Research Council under the European Union’s Horizon 2020 research and innovation programme grant no: 677542 to JD. RRD was supported by a Juan de la Cierva contract (IJCI-2017-31399). There is no financial or personal relationship with organizations that could potentially influence the described research.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of endoplasmic reticulum stress-associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm

  • Almendra-Pegueros, Rafael
  • Rodríguez-Sinovas, Cristina
  • Camacho, Mercedes
  • Sánchez-Infantes, David
  • Sánchez-Quesada, José Luís
  • Cáncer, Susana
  • Pérez-Marlasca, Elvira
  • Medina-Gómez, Gema
  • Martínez-González, José
  • García-Redondo, Ana B.
  • Galán, María
Endoplasmic reticulum (ER) stress plays a critical role in the abdominal aortic aneurysm (AAA), a life-threatening disease characterized by inflammation, destructive remodeling, and vascular smooth muscle cells (VSMCs) dysfunction. The current therapy relies on surgical repair, but no effective pharmacological strategies are available to limit aneurysm progression. Long non-coding RNAs (lncRNAs) are essential factors in health and disease; however, their specific contribution to AAA development and its relationship with ER stress remain unexplored. Here, we have performed a whole-genome transcriptomic analysis characterizing the expression profile of lncRNAs in AAA. RNA sequencing was carried out in abdominal aorta from patients with AAA and healthy donors. We identified 6576 differentially expressed (DE)-mRNAs and 1283 DE-lncRNAs. Interestingly, bioinformatic analysis revealed a set of 368 DE-lncRNAs related to ER stress. The differential expression of the most induced lncRNAs (IL-21-AS1, ITPKB-IT, PCED1B-AS1, TCL-6, LINC00494, LINC00582, LINC00626, LINC00861, and LINC00892) was validated in a large cohort of patients with AAA. The ability of these selected lncRNAs to discriminate patients with AAA from healthy subjects was established by receiveroperating characteristic curves and logistic regression analysis. In human aortic VSMC and Jurkat T-cells, tunicamycin-induced ER stress triggered the expression of IL21-AS1, LINC00626, LINC00494, LINC00892, PCED1B-AS1, ITPKB-IT, and TCL-6, while tauroursodeoxycholic acid counteracted these effects. Finally, an integrated analysis of mRNA-lncRNA co-expression revealed the correlation between the selected lncRNAs and the DE-mRNAs involved in immune response and muscle contraction. Therefore, these DE-lncRNAs potentially implicated in the ER stress response, a pathological process in AAA, could be considered as potential therapeutic target to handle AAA., This work was funded in part by the Instituto de Salud Carlos III (ISCIII) under grant [PI20/01004] to M.G., [PI21/01048] to C.R., in part by “ERDF A way of making Europe,” and in part by Ministerio de Ciencia, Innovación y Universidades (MCIN) under grant [PID2020 116498RB-I00] to A.G-R. R.A-P is supported by a PFIS fellowship [FI21/00125, ISCIII]. M.G. was hired under the Miguel Servet Program [ISCIII. Ref. CP20/00013]. The study has been carried out within the framework of the Doctorate Program in Pharmacology of the Autonomous University of Barcelona., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure and properties of citrus pectin as influencing factors of biomarkers of metabolic syndrome in rats fed with a high-fat diet

  • Méndez-Albiñana, Pablo
  • Rodrigues-Díez, Raquel
  • Rodríguez-Rodríguez, Pilar
  • Moreno, Rodrigo
  • Muñoz-Valverde, David
  • Casani, Laura
  • Villamiel, Mar
  • Blanco-Rivero, Javier
Pectin, widely used as a food and pharmaceutical ingredient, has garnered attention in recent years due to its bioactive properties. We conducted an in vivo study to evaluate the effects of citrus pectin on biomarkers of metabolic syndrome (MtS), including lipid profile, hypertension, and adipose tissue. Supplementing a high-fat diet (60% energy from fat) with 20% pectin for 4 weeks significantly reduced body weight and fat accumulation, improved insulin resistance, and decreased circulating leptin levels, demonstrating a beneficial effect on MtS. Pectin exhibited excellent viscosity, emulsifying properties, and water-holding capacity, forming a viscous gel in the gastrointestinal tract. This gel delays gastric emptying, enhances satiety, and reduces food and calorie intake, leading to lower weight gain in rats fed pectin. Its viscosity also interferes with lipase activity, lipid hydrolysis, and absorption, while its oil-holding capacity may help prevent lipid absorption. The presence of galactose in pectin's structure showed potential for improving insulin resistance. Furthermore, both degree of esterification (DE) and pH influence pectin's functionality. At acidic pH levels, such as those found in the stomach and duodenum, high methoxyl pectin (HMP) retains fats and bile salts more effectively, contributing to better cholesterol regulation. These effects, combined with the antioxidant properties of pectin, helped reverse arterial hypertension associated with MtS. Overall, our findings highlight the potential of citrus pectin as a natural bioactive ingredient for combating obesity-related disorders, complementing pharmacological treatments and promoting health through innovative dietary approaches., This research was funded by CiberCV (Grant number: CB16/11/00286), and the Ministerio de Ciencia e Innovación (PID2020-116498RB-100, PID2021-123862OB-100, PID2022-138,610OB- 100), CDTI -Center for Industrial Technological Development-project PID 2020-FEDER Funds), and Luis Álvarez Fellowship (IdIPaz, 2023 Call)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: role of perivascular mesenteric innervation

  • Méndez-Albiñana, Pablo
  • Cros-Brunsó, Laia
  • Rodrigues-Díez, Raquel
  • Rodríguez-Rodríguez, Pilar
  • Santamaría, Luis
  • Muñoz Labrador, Ana
  • Requena, Teresa
  • Caballero, Francisco Félix
  • Prieto-Nieto, Mª Isabel
  • Villamiel, Mar
  • Blanco-Rivero, Javier
Liver cholestasis is marked by bile acid accumulation in the liver, along with renal issues, portal hypertension, and altered circulation. Previous studies suggest that synbiotics may improve systemic and hemodynamic conditions in liver diseases. This study investigated the effects of a commercial synbiotic on gut microbiota, liver and kidney function, and vascular changes in a cholestatic rat model, focusing on nerve functions in the superior mesenteric arteries. Adult male Wistar rats were divided into three groups: Sham-operated, Cholestatic, and Cholestatic supplemented with a synbiotic for 3 weeks, following an initial 3-week postsurgical recovery period for model establishment. The synbiotic did not significantly alter gut microbiota composition, but reduced endotoxemia and increased butyric, acetic, and propionic acid levels. It improved, but did not fully reverse, liver and renal damage. In the synbiotic group, systolic blood pressure normalized to values similar to sham-operated animals, and mesenteric artery vasoconstriction increased in response to electric field stimulation. Although the vasomotor response to noradrenaline (NA) remained unchanged, NA release was higher (P < 0.05), indicating increased sympathetic activity due to symbiotic administration. Nitric oxide (NO) response did not change, but neuronal nitric oxide synthase (nNOS) expression and NO release increased after symbiotic supplementation (P < 0.05). Additionally, calcitonin gene-related peptide (CGRP) levels and function were reduced by synbiotics to control values (P < 0.05). In conclusion, synbiotic administration improved systemic, hepatic, renal, and vascular alterations associated with cholestasis in rats, suggesting that microbiota-directed therapies may represent a promising approach to mitigate complications of liver disease., This research was funded by CiberCV (Grant number: CB16/11/00286), and the Ministerio de Ciencia e Innovación (PID 2020-116498RB-100, PID 2021-123862OB-100, PID 2022-138610OB- 100) and CDTI -Center for Industrial Technological Development-project PID 2020-FEDER Funds)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: Role of perivascular mesenteric innervation [Dataset]

  • Méndez-Albiñana, Pablo
  • Cros-Brunsó, Laia
  • Rodrigues-Díez, Raquel
  • Rodríguez-Rodríguez, Pilar
  • Santamaría, Luis
  • Muñoz Labrador, Ana
  • Requena, Teresa
  • Caballero, Francisco Félix
  • Prieto-Nieto, Mª Isabel
  • Villamiel, Mar
  • Blanco-Rivero, Javier
This dataset is supplementary material for the paper: "Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: role of perivascular mesenteric innervation". It contains 6 tables and 7 figures., Instituto de Salud Carlos III: CB16/11/00286, Agencia Estatal de Investigación: PID2020-116498RB-I00, Agencia Estatal de Investigación: PID2021-123862OB-I00, Agencia Estatal de Investigación: PID2022-138610OB-I00, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interferon stimulated gene 15 (ISG15) modulates phenotype of vascular smooth muscle cells and pathological vascular remodeling El gen estimulado por interferón 15 (ISG15) modula el fenotipo de células musculares lisas vasculares y el remodelado vascular patológico

  • Soudant, Julius
  • González-Blázquez, Raquel
  • Merino, Abraham
  • Ballesteros-Martínez, Constanza
  • Rodrigues-Diez, Raquel
  • Moreno-Carriles, Rosa
  • Nistal, J. Francisco
  • Guerra, Susana
  • Redondo, Juan Miguel
  • Salaices, Mercedes
  • Briones, Ana M
  • García-Redondo, Ana B
Introduction: Inflammation is a major determinant of abdominal aortic aneurysms (AAA). Interferon stimulated gene 15 (ISG15) has a role in vascular remodelling in AAA. This study investigates the mechanisms whereby ISG15 might affect vascular remodeling and function. Methods: We used vascular smooth muscle cells (VSMC) from wild type (ISG15) o ISG15 knockout (ISG15) mice, aorta from ISG15 and ISG15 mice infused with angiotensin II (1.44 mg/kg/day, sc, 14 days), and human AAA. We also performed a model of recombinant ISG15 infusion (rISG15, sc, 100 and 500 ng/day, 14 days) in mice. Results: In VSMC, ISG15 deficiency increased the expression of contractile (Acta2, Tagln) and synthetic (Fn1, Col1a2, Col3, Col4) markers and decreased the expression of the calcification marker Spp1. Ang II infusion changed the expression of phenotype markers differently in aorta from ISG15 or ISG15 mice. ISG15 expression showed a negative correlation with expression of contractile markers (ACTA2, CNN1), and with COL3a1, in human samples from patients with AAA or with stenotic aorto-iliac pathology. rISG15 infusion induced hypotrophic vascular remodelling in mesenteric arteries without affecting vascular mechanics. Aorta of ISG15 mice contracted more to thromboxane A analogue U46619, compared to ISG15mice. Both aorta and mesenteric arteries from rISG15-treated mice showed less contractility than control mice. Conclusions: ISG15 participates in pathological vascular remodeling probably by modulating VSMC phenotype. These changes could also impact in the vascular function., This work was undertaken thanks to funding from the Spanish Arteriosclerosis Foundation (FEA Grant 2021- Basic Research). In addition, the study received funding from MCIN/AEI/10.13039/501100011033 and from ’’ERDF A way of making Europe’’, PID2020-116498RB-I00, through the RED2022-134541-T research networks funded by MICIU/AEI/10. 13039/501100011033 and PI21/00084, from the Social Security Health Research Fund
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dasatinib reversibly disrupts T cell motility and activation in lymph nodes

  • Carvoeiro, Daniela Claudino
  • Marcos-Jiménez, Ana
  • Tsukalov, Ilya
  • Viñas i Palou, Clara
  • Luquin, Sergio Sanchez
  • Eladnani, Ihssane
  • Hernanz, Raquel
  • Briones, Ana M.
  • Martín-Gayo, Enrique
  • Martín-Gayo, Enrique
  • Stein, Jens V.
The tyrosine kinase inhibitor dasatinib is prescribed as a first-line treatment for Philadelphia chromosome–positive leukemias and is increasingly used in other clinical settings. While dasatinib is effective and generally well tolerated, patients often experience a transient lymphocytosis attributable to a dasatinib-induced spleen contraction and an acute mobilization of splenocytes, as we have recently demonstrated in murine models and human patients. In contrast, the impact of dasatinib on lymphocyte surveillance of other secondary lymphoid organs, such as peripheral lymph nodes (LNs), has remained unclear. Here, we report that while dasatinib treatment selectively disrupted in vitro chemotaxis of B but not T cells, it caused a substantial, transient reduction of the in vivo interstitial motility in both subsets. The broad in vivo inhibition of T and B cell motility correlated with dasatinib-induced vasoconstriction of blood vessels and increased hypoxia within LNs. Pharmacological inhibition of the contraction-promoting factor Rho-associated coiled-coil kinase (ROCK) reversed dasatinib-induced LN hypoxia and rescued CD8 T cell motility. Last, dasatinib treatment delayed but did not inhibit dendritic cell–mediated CD8 T cell activation and proliferation within LNs. Overall, our findings uncover a dasatinib-induced transient disruption of the local adaptive immune system, which is distinct from the previously observed spleen contraction. From a clinical point of view, the disruption-recovery cycle of physiological immune surveillance induced by daily dasatinib treatment does not appear to cause a substantial impairment of key pathways underpinning CD8 T cell activation., This work was supported by the San Salvatore Foundation (J.V.S and C.M.-C.); Swiss National Foundation grants 31003A_172994, 310030_200406, and 320030-236044 (J.V.S.); Spanish Instituto de Investigación Carlos III (ISCIII) grant PI21/01803 (C.M.-C.); ISCIII grant JR23/00062 cofunded by European Social Fund, “Investing in your future” (A.M.-J.); The Spanish Agencia Estatal de Investigación Generación de Conocimiento and Consolidation programs PID2021-127899OB-I00 and CNS2023-144841 (E.M.-G.); Gilead Biosciences grant GLD24/00117 (E.M.-G.); Infectious Diseases CIBER from ISCIII (CIBERINFECC) (C.M.-C. and E.M.-G.).; Spanish Ministry of Science Innovation and Universities, Beca de Formación de Profesorado Universitario (FPU) (I.T.); and Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and ERDF “A way of making Europe” grant PID2020-116498RB-I00 (A.M.B.).
e-cienciaDatos, Repositorio de Datos del Consorcio Madroño
Datos de investigación Set de datos (Dataset)

Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: Role of perivascular mesenteric innervation

  • Méndez Albiñana, Pablo
  • Cros-Brunsó, Laia
  • Rodrigues Díez, Raquel
  • Rodríguez Rodríguez, Pilar
  • Santamaría Solís, Luis Vicente
  • Muñoz-Labrador, Ana
  • Requena, Teresa
  • Casaní, Laura
  • Caballero, Francisco Félix
  • Prieto Nieto, Maria Isabel
  • Villamiel, Mar
  • Blanco Rivero, Javier
<p>Effect of synbiotic supplementation on the body alterations in a rat model of liver colestasis.</p> <p>This dataset is supplementary material for the paper: "Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: role of perivascular mesenteric innervation". It contains 6 tables and 7 figures.</p> <ul> <p>Background</p> <p>Liver cholestasis is marked by bile acid accumulation in the liver, along with renal issues, portal hypertension, and altered circulation. Previous studies suggest that synbiotics may improve systemic and hemodynamic conditions in liver diseases.</p> <p>Objective</p> <p>This study investigated the effects of a commercial synbiotic on gut microbiota, liver and kidney function, and vascular changes in a cholestatic rat model, focusing on nerve functions in the superior mesenteric arteries.</p> </p>Methodology</p> <p>Adult Wistar rats were divided into three groups: Sham-operated, Cholestatic, and Cholestatic with synbiotic supplementation for 3 weeks. Liver colestasis was induced by surgical techniques. Blood pressure was measured using tail-cuff method.Liver and renal structure were determined using histological techniques (hematoxilin-eosin tinction). Liver and renal parameters in serum were measured using spectrophotometrical techniques. Short chain fatty acids were determined through liquid chromatography. Gene expression in kidney and fecal simples were determined by qRT-PCR. Vasomotor responses in superior mesenteric artery were determined by vascular reactivity techniques (organ bath).Neurotransmitter and endotoxin releases were measured using enzymeinmunoassay and fluorescence techniques. Protein expression was measured using western blot.</p> </ul>